Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dataset wrap
Namept
Rowcaps
Rows 1-20:Show several analytes (as noted in the PTTEST) in the E-Liquid substance for the condition noted in PTTSTCND which is Condition 1. 
Rows 2, 12, 13:Show the Nicotine, 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), and N-nitrosonornicotine analytes in the Aerosol substance represented using the PTSPEC variable.
Rows 17, 18:Show microbials, TAMC and TYMC (PTTEST and PTTESTCD), used in testing (aerobic plate count, mold, and yeast) using the PTSCAT variable. The E-Liquid substance has the condition represented using the PTTSTCND which is Condition 1.  
Dataset2
RowSTUDYIDDOMAINSPTOBIDSPDEVIDSTOCONDIDPTSEQPTREFIDPTTESTCDPTTESTPTCATPTSCATPTORRESPTORRESUPTLLODPTSTRESCPTSTRESNPTSTRESUPTSPECPTSPCCNDPTMETHODPTLLOQPTREPNUMPTTPTPTTPTNUM
1TOB07PT111
Condition 1

1

VAP77777.1NICOTINENicotineSTABILITY STUDY
35.94mg/g
35.9435.94mg/gE-LIQUID


1Week 01
2TOB07PT111
Condition 12VAP77777.1NICOTINENicotineSTABILITY STUDY

0.1039

mg/PUFF
0.10390.1039mg/PUFFAEROSOL


1Week 01
3TOB07PT111
Condition 13VAP77777.1NORNCTN

Nornicotine

STABILITY STUDYNicotine Degradant25.76ug/g
25.7625.76ug/gE-LIQUID


1Week 01
4TOB07PT111
Condition 134VAP77777.1NORNCTN

Nornicotine

STABILITY STUDYNicotine Degradant0.0392ug/PUFF
0.03920.0392ug/PUFFAEROSOL


1Week 01
5TOB07PT111
Condition 15VAP77777.1GLYCRLGlycerolSTABILITY STUDYPrimary Ingredient615.68mg/g
615.68615.68mg/gE-LIQUID


1Week 01
6TOB07PT111
Condition 156VAP77777.1GLYCRLGlycerolSTABILITY STUDYPrimary Ingredient1.81mg/PUFF0.001441.811.81mg/PUFFAEROSOL


1Week 01
7TOB07PT111
Condition 167VAP77777.1PRPYLGLYPropylene GlycolSTABILITY STUDYPrimary Ingredient218.21mg/g
218.21218.21mg/gE-LIQUID


1Week 01
8TOB07PT111
Condition 168VAP77777.1PRPYLGLYPropylene GlycolSTABILITY STUDYPrimary Ingredient0.8565mg/PUFF0.000240.85650.8565mg/PUFFAEROSOL


1Week 01
9TOB07PT111
Condition 179VAP77777.1BNZOICACBenzoic AcidSTABILITY STUDYAcid42.2ug/PUFF
42.242.2ug/PUFFE-LIQUID


1Week 01
10TOB07PT111
Condition 1810VAP77777.1MENTHOLMentholSTABILITY STUDYFlavorant37.53mg/g
37.5337.53mg/gE-LIQUID


1Week 01
11TOB07PT111
Condition 1811VAP77777.1MENTHOLMentholSTABILITY STUDYFlavorant0.5881mg/PUFF0.000240.58810.5881mg/PUFF

AEROSOL




1Week 01
12TOB07PT111
Condition 112VAP77777.1GLYCDOLGlycidolSTABILITY STUDYStabilizer<Limit of Detection (LOD)
0.00011<Limit of detection (LOD)

AEROSOL




1Week 01
13TOB07PT111
Condition 113VAP77777.1FRMLDHDFormaldehydeSTABILITY STUDY
0.0728ug/PUFF0.005490.07280.0728ug/PUFF

AEROSOL




1Week 01
14TOB07PT111
Condition 114VAP77777.1ACROLNAcrolienSTABILITY STUDY
<Limit of Quantification (LOQ)
0.00928Limit of Quantification (LOQ)

AEROSOL




1Week 01
15TOB07PT111
Condition 115VAP77777.1LACTICACLactic AcidSTABILITY STUDY
40.44ug/g
40.4440.44ug/g

E-LIQUID




1Week 01
16TOB07PT111
Condition 116VAP77777.1LACTICACLactic AcidSTABILITY STUDY
29.71ug/PUFF0.28429.7129.71ug/PUFF

AEROSOL




1Week 01
17TOB07PT111
Condition 1917VAP77777.1VANLLNVanillinSTABILITY STUDYFlavorant1.12ug/g
1.121.12ug/gE-LIQUID


1Week 01
18TOB07PT111
Condition 11018VAP77777.1NNKNicotine-Derived Nitrosamine KetoneSTABILITY STUDYHPHC0.0711ug/g
0.07110.0711ug/gE-LIQUID


1Week 01
19TOB07PT111
Condition 11119VAP77777.1NNNN-NitrosonornicotineSTABILITY STUDYHPHC0.0852ug/g
0.08520.0852ug/gE-LIQUID


1Week 01
20TOB07PT111
Condition 11220VAP77777.1NNKNicotine-Derived Nitrosamine KetoneSTABILITY STUDYHPHC0.0577ug/PUFF
0.05770.0577ug/PUFFAEROSOL


1Week 01
21TOB07PT111
Condition 11321VAP77777.1NNNN-NitrosonornicotineSTABILITY STUDYHPHC0.0742ug/PUFF
0.07420.0742ug/PUFFAEROSOL


1Week 01
22TOB07PT111
Condition 11422VAP77777.1NICKELNickelSTABILITY STUDYExtractables / Leachables 0.0897ug/g
0.08970.0897ug/gE-LIQUID


1Week 01
23TOB07PT111
Condition 11423VAP77777.1MASSMassSTABILITY STUDY
3.87mg/PUFF0.00713.873.87mg/PUFFAEROSOL


1Week 01
24TOB07PT111
Condition 11424VAP77777.1CHROMIUMChromiumSTABILITY STUDY
NOT DETECTED

NOT DETECTED

E-LIQUID


1Week 01
25TOB07PT111
Condition 11525VAP77777.1PHpHSTABILITY STUDY
7.15

7.157.15
E-LIQUID


1Week 01
26TOB07PT111
Condition 11526VAP77777.1PHpHSTABILITY STUDY
7.24

7.247.24
AEROSOL


1Week 01
27TOB07PT111
Condition 11627VAP77777.1ENDTXNEndotoxinSTABILITY STUDYToxinsNOT DETECTED

NOT DETECTED

E-LIQUID


1Week 01
28TOB07PT111
Condition 11728VAP77777.1AEBPLCTAerobic Plate CountSTABILITY STUDYMicrobiological<1 CFU/mL
<1 <1 CFU/mLE-LIQUID


1Week 01
29TOB07PT111
Condition 11829VAP77777.1TYMCTotal Yeast and/or Mold CountSTABILITY STUDYMicrobiological1CFU/mL
11CFU/mLE-LIQUID


1Week 01
30TOB07PT111
Condition 11930VAP77777.1ACTALDAcetaldehydeSTABILITY STUDYAldehyde7.8ug/mL
7.87.8ug/mLE-LIQUID


1Week 01
31TOB07PT111
Condition 12031VAP77777.1ACTPROPNAcetyl PropionylSTABILITY STUDYDiketone32.4ug/mL
32.432.4ug/mLE-LIQUID


1Week 01

A Shelf Life study dataset would shows analytes done in different test conditions with replicates over time points.  In the interest of brevity for this example, only portions of the content using the TEST of Nicotine is shown in a sample of timepoints in two conditions with replicates. The weeks reflective of Week 1,  Week 2, Week 3, etc. which would align with the PTTPTNUM of 2,3, etc. are not shown for visual viewing purposes. This is an example, this provides possible tests that might be used to demonstrate how to use the datasets and variables to show what was done for the shelf-life stability study. It shows what timepoint and what type of data follows. It is important to show different test conditions for each analyte. For aerosol a machine similutaion is use so mg/puff is valid.

...